Denali Therapeutics (DNLI) Other Operating Expenses (2024)
Denali Therapeutics (DNLI) reported Other Operating Expenses of $14.5 million for Q1 2024.
Denali Therapeutics (DNLI) Other Operating Expenses (2024) Analysis & Trends
Denali Therapeutics (DNLI) has 1 years of Other Operating Expenses data on file, last reported at $14.5 million in Q1 2024.
- Other Operating Expenses for Q1 2024 came in at $14.5 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2024 was $14.5 million (changed N/A YoY), and the FY2024 annual result was $14.5 million, changed N/A from the prior year.
- Other Operating Expenses was little changed at $14.5 million in Q1 2024 per DNLI's latest filing.
- Over five years, Other Operating Expenses peaked at $14.5 million in Q1 2024 and troughed at $14.5 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Denali Therapeutics | 4.35 Bn | 4.35 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 14.54 Mn |